Skip to search formSkip to main contentSkip to account menu

tranilast

Known as: 2-((3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid, 2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid, N-(3',4'-dimethoxycinnamoyl)anthranilic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Gemcitabine (Gem) is a dFdC analogue with activity against several solid tumors. Gem is intracellularly phosphorylated by dCK… 
2007
2007
Tranilast is an oral antiallergic agent widely used in Japan. Recently, in Western populations, hyperbilirubinemia induced by… 
2004
2004
BACKGROUND Some drugs such as phenytoin, calcium blockers, or cyclosporins are known to cause gingival fibrous hyperplasia, an… 
2001
2001
Cardiac allograft vasculopathy is a major complication after cardiac transplantation, often limiting long-term recipient survival… 
Highly Cited
1996
Highly Cited
1996
The aim of this study was to examine the effects of tranilast (anti-allergic drug) on proliferation, migration, and collagen… 
1996
1996
1 Newborn human vascular smooth muscle cells (VSMCs) proliferated faster and were more sensitive to platelet‐derived growth… 
1987
1987
The relative in vitro antioxidant efficacy of tranilast, a new orally active anti-allergic agent, was examined by studying its… 
1986
1986
A new anti‐allergic drug, tranilast [N‐(3′,4′‐dimethoxycinnamoyl) anthranilic acid] was used on a 46‐year‐old Japanese female… 
1985
1985
We found that N-(trans-3, 4-dimethoxycinnamoyl) anthranilic acid (tranilast) is readily transformed by photo-irradiation to N…